References
- Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993;328(17):1230–5.
- Pankow W, Nabe B, Lies A, et al. Influence of sleep apnea on 24-hour blood pressure. Chest 1997;112(5):1253–8.
- Ringler J, Basner RC, Shannon R, et al. Hypoxemia alone does not explain blood pressure elevations after obstructive apneas. Eur J Appl Physiol 1990;69(6):2143–8.
- Young T, Finn L, Peppard PE, et al. Sleep disordered breathing and mortality: Eighteen-year follow-up of the Wisconsin sleep cohort. Sleep 2008;31(8):1071–8.
- Logan AG, Perlikowski SM, Mente A, et al. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens 2001;19(12):2271–7.
- Peppard PE, Young T, Palta M, et al. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000;342(19):1378–84.
- Somers VK, Dyken ME, Clary MP, et al. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest.1995;96(4):1897–904.
- Armstrong C. JNC8 guidelines for the management of hypertension in adults. Am Fam Physician 2014;90(7):503–4.
- Officers A, Coordinators for the ACRGTA, Lipid-Lowering Treatment to Prevent Heart Attack T. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002;288(23):2981–97.
- Staessen JA, Bieniaszewski L, O’Brien ET, et al. Special feature: What is a normal blood pressure in ambulatory monitoring? Nephrology Dialysis Transplantation 1996;11(2):241–5.
- O’Brien E, Sheridan J, O’Malley K. Dippers and non-dippers. Lancet 1988;2(8607):397.
- Byrd JB, Brook RD. Arm position during ambulatory blood pressure monitoring: A review of the evidence and clinical guidelines. J Clin Hypertens 2014;16(3):225–30.
- Bertinieri G, Dirienzo M, Cavallazzi A, et al. Evaluation of baroreceptor reflex by blood-pressure monitoring in unanesthetized cats. Am J Phys 1988;254(2):H377–H83.
- Milic M, Sun P, Liu F, et al. A comparison of pharmacologic and spontaneous baroreflex methods in aging and hypertension. J Clin Hypertens 2009;27(6):1243–51.
- Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 1996;93(5):1043–65.
- Pyke KE, Tschakovsky ME. The relationship between shear stress and flow-mediated dilatation: implications for the assessment of endothelial function. J Physiol 2005;568(Pt 2):357–69.
- Laurent S, Cockcroft J, Van Bortel L, et al. Expert consensus document on arterial stiffness: Methodological issues and clinical applications. Eur heart J 2006;27(21):2588–605.
- Ziegler MG, Mills PJ, Loredo JS, et al. Effect of continuous positive airway pressure and placebo treatment on sympathetic nervous activity in patients with obstructive sleep apnea. Chest 2001;120(3):887–93.
- Parati G, Di Rienzo M, Bonsignore MR, et al. Autonomic cardiac regulation in obstructive sleep apnea syndrome: evidence from spontaneous baroreflex analysis during sleep. J Hypertens 1997; 15 (12 Pt 2): 1621–6.
- Cortelli P, Parchi P, Sforza E, et al. Cardiovascular autonomic dysfunction in normotensive awake subjects with obstructive sleep apnoea syndrome. Clin Auton Res 1994;4(1–2):57–62.
- Carlson JT, Hedner JA, Sellgren J, et al. Depressed baroreflex sensitivity in patients with obstructive sleep apnea. Am. J. Respir Crit Care Med 1996;154(5):1490–6.
- Ziegler MG, Nelesen RA, Mills PJ, et al. The effect of hypoxia on baroreflexes and pressor sensitivity in sleep apnea and hypertension. Sleep 1995;18(10):859–65.
- Narkiewicz K, Pesek CA, Kato M, et al. Baroreflex control of sympathetic nerve activity and heart rate in obstructive sleep apnea. Hypertension 1998;32(6):1039–43.
- Lake CR, Ziegler MG, Coleman MD, et al. Hydrochlorothiazide-induced sympathetic hyperactivity in hypertensive patients. Clin Pharmacol Ther. 1979;26(4):428–32.
- Gupta S, Wright HM. Nebivolol: A highly selective beta1-adrenergic receptor blocker that causes vasodilation by increasing nitric oxide. Cardiovasc Ther 2008;26(3):189–202.
- Van de Water A, Janssens W, Van Neuten J, et al. Pharmacological and hemodynamic profile of nebivolol, a chemically novel, potent, and selective beta 1-adrenergic antagonist. J Cardiovasc Pharmacol 1988;11(5):552–63.